Skip to content

Erytra 210401Recalls & reported problems

Diagnostic Grifols SA · The Erytra is a fully-automated high-throughput analyzer designed to automate in vitro immunohematologial test of human blood utilizing DG Gel 8 card technology, including Blood Grouping, Antigen Typing, Antibody Screening, Antibody Identification, Compatability Tests, and Direct Antiglobulin Tests. As a standalone analyzer or interfaced to the customer's Laboratory Information System (LIS), the Erytra automates test processing functions and data management requirements using DG Gel 8 cards and digital image processing. · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08437014205190), received between Jun 4, 2020 and Jun 4, 2020 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device Displays Incorrect Message” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Device Displays Incorrect Message1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 4, 2020Device Displays Incorrect Message; Device Displays Incorrect Message

    ON (B)(6) 2020, THE CUSTOMER (B)(6), REPORTED TO GRIFOLS A SAMPLE BARCODE READING ERROR OCCURRED DURING THE VALIDATION/CORRELATION OF A CROSSMATCH TEST. THE ERYTRA FULLY AUTOMATED IMMUNOHEMATOLOGY ANALYZER READ THE DONOR SAMPLE BARCODE AS (B)(6) INSTEAD OF THE EXPECTED NUMBER (B)(6). THE EVENT WAS DETECTED BY THE OPERATOR WHEN CHECKING THE BARCODES TO REPEAT THE CROSSMATCH TESTS MANUALLY. THE SAME BARCODE WAS LATER READ AGAIN WITH THE SAME INSTRUMENT AND WITH ANOTHER ERYTRA ANALYZER, AND THE BARCODE WAS READ CORRECTLY. THE CUSTOMER CONFIRMS THAT THIS WAS THE FIRST AND ONLY TIME THE DEVICE HAS MISREAD A BARCODE NUMBER. THE BARCODE WAS AN ISBT128 WITH CHECKSUM FROM A DONOR'S BAG FROM THE RED CROSS UNIT. NOTE THAT WHEN THE CUSTOMER IS WORKING IN ROUTINE CONDITIONS, THE INSTRUMENT IS INTERFACED WITH THE LIS. THE LIS WOULD DETECT THE DISCREPANCY BECAUSE THE WRONG CODE EITHER WOULD NOT EXIST OR WOULD NOT CORRESPOND TO A SAMPLE PREVIOUSLY SENT TO THE ANALYZER, PRECLUDING THE POSSIBILITY OF RELEASING THE ASSOCIATED TESTS RESULT TO AN INCORRECT SAMPLE IDENTIFICATION NUMBER.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 10117514 ↗

Other System, Test, Automated Blood Grouping And Antibody devices

All System, Test, Automated Blood Grouping And Antibody devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.